Your Feed

Filter by
See content from
Back to the latest
Thumbnail for Beyond IMiDs: Cemsidomide — A Next-Generation Cereblon Degrader Shows Promise in Myeloma | EHA 2026
Playlist: EHA 2026

Beyond IMiDs: Cemsidomide — A Next-Generation Cereblon Degrader Shows Promise in Myeloma | EHA 2026

Video details & playlist
Thumbnail for Talquetamab Steps Forward: MonumenTAL-3 - A New Potential for GPRC5D Therapy in Myeloma | EHA 2026
Playlist: EHA 2026

Talquetamab Steps Forward: MonumenTAL-3 - A New Potential for GPRC5D Therapy in Myeloma | EHA 2026

Video details & playlist
Thumbnail for CAR-T Without the Wait: Reprogramming T-cells Inside Your Body for Myeloma | EHA 2026
Playlist: EHA 2026

CAR-T Without the Wait: Reprogramming T-cells Inside Your Body for Myeloma | EHA 2026

Video details & playlist
Thumbnail for Next Generation of CAR-T: AZD0120 Dual BCMA/CD19 CAR-T w/ Rapid Manufacturing for Myeloma | EHA 2026
Playlist: EHA 2026

Next Generation of CAR-T: AZD0120 Dual BCMA/CD19 CAR-T w/ Rapid Manufacturing for Myeloma | EHA 2026

Video details & playlist
Thumbnail for Next Generation of CAR-T: AZD0120 Dual BCMA/CD19 CAR-T w/ Rapid Manufacturing for Myeloma | EHA 2026
Playlist: EHA 2026

Next Generation of CAR-T: AZD0120 Dual BCMA/CD19 CAR-T w/ Rapid Manufacturing for Myeloma | EHA 2026

Video details & playlist
Thumbnail for Beyond MRD Negative: FORTE Trial Reveals Why Staying MRD Negative Matters in Myeloma | ASCO 2026
Playlist: EHA 2026

Beyond MRD Negative: FORTE Trial Reveals Why Staying MRD Negative Matters in Myeloma | ASCO 2026

Video details & playlist
Thumbnail for Duffy Null & High-Risk Myeloma in Black Patients: Insights from CoMMpass & HORIZON Study | EHA 2026
Playlist: EHA 2026

Duffy Null & High-Risk Myeloma in Black Patients: Insights from CoMMpass & HORIZON Study | EHA 2026

Video details & playlist
Avatar
jg1949
Acute Myeloid Leukemia Discussion • June 28
Just informed I have AML and a bit foggy
I am 77 years old and live alone but have relatives near by. I don't know if this is the right place or not to find out about Hospice care? If someone could point me in the right direction it would be greatly appreciated!
Avatar
Pheba1
Multiple Myeloma Discussion • June 27
What causes MM?
On Wednesday of last week I attended a birthday party for a friend in my sewing group. She just turned 90. I baked the cake. My first layer cake in decades, a carrot cake. It turned out great. After food and cake we sat around the table chatting. They know I have MM. Then they went around the table in a circle talking about family members, and friends they know with MM. There were 7 ladies and 7 family members or friends with MM. I was floored. Why so many? I saw my oncologist on Thursday. I told him about the party. He said MM was endemic in our area. I asked him what caused it. He said cancer is caused by 3 things; what we do to our self, what the environment does to us, and what we inherit from our ancestors. That was as clear as an answer as I could get. I am guessing that the truth is that doctors and scientist suspect what causes some cancers, but have no proof. I do know I live in a rural area with farming and pesticides. The neighbor behind us died two years ago from Leukemia. Another neighbor died two years ago from Leukemia also. I suspect it may be more complicated. We have something called epi-genes, genes that turn genes on or off. Some people have epi-genes that can mutate a chromosome when exposed to a cancer causing agent. Others have epi-genes that do not get turned on, even if they take a bath in a pesticide. We may never know, but I find the coincidence of MM being endemic in our area interesting.
Thumbnail for Is Autologous Stem Cell Transplant Still Standard of Care in Myeloma? New Data from EHA 2026
Playlist: EHA 2026

Is Autologous Stem Cell Transplant Still Standard of Care in Myeloma? New Data from EHA 2026

Video details & playlist
Thumbnail for Arlocabtagene Autoleucel (Arlo-Cel): Promising GPRC5D CAR-T Results in Relapsed Myeloma | EHA 2026
Playlist: EHA 2026

Arlocabtagene Autoleucel (Arlo-Cel): Promising GPRC5D CAR-T Results in Relapsed Myeloma | EHA 2026

Video details & playlist
Thumbnail for CAR-T vs Bispecifics — Which Performs Better in Myeloma After Initial BCMA Therapy Fails? | #EHA2026
Playlist: EHA 2026

CAR-T vs Bispecifics — Which Performs Better in Myeloma After Initial BCMA Therapy Fails? | #EHA2026

Video details & playlist
Thumbnail for A New Way to Deliver Isatuximab in Myeloma: Safety Insights on the On-Body Injector (OBI) | #EHA2026
Playlist: EHA 2026

A New Way to Deliver Isatuximab in Myeloma: Safety Insights on the On-Body Injector (OBI) | #EHA2026

Video details & playlist
Thumbnail for BMS-986453 : A Next-Generation Dual-Target CAR-T Attacking BCMA + GPRC5D in Myeloma | #EHA2026
Playlist: EHA 2026

BMS-986453 : A Next-Generation Dual-Target CAR-T Attacking BCMA + GPRC5D in Myeloma | #EHA2026

Video details & playlist
Thumbnail for MajesTEC-4 / EMN30 Trial: Is Teclistamab the Future of Myeloma Maintenance After Transplant? | EHA26
Playlist: EHA 2026

MajesTEC-4 / EMN30 Trial: Is Teclistamab the Future of Myeloma Maintenance After Transplant? | EHA26

Video details & playlist